Nang Kuang Pharmaceutical Co., Ltd. (TWSE: 1752)
Health Care · Pharmaceuticals · TW
NT$32.00
+0.16% today · -9.1% 1Y
Nang Kuang Pharmaceutical Co., Ltd. (TWSE: 1752) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $101.49M and employs 552 people.
Over the last twelve months the share price has lost 9.1%, trading between 31.10 and 40.70.
Tweenvest scores Nang Kuang Pharmaceutical Co., Ltd. across four factors: quality 66/100, value 60/100, dividend 90/100. Its strongest factor is dividend.
1752 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $101.49M
- Revenue (TTM)
- $66.30M
- P/E
- 15.77
- EPS
- 2.03
- Dividend yield
- 5.00%
- Beta (5Y)
- 0.13
- 52-week high
- NT$40.70
- 52-week low
- NT$31.10
- Avg volume (3M)
- —
- Shares outstanding
- 100.99M
- Employees
- 552
- Next earnings
- —
About Nang Kuang Pharmaceutical Co., Ltd.
Primarily based in Taiwan, Nang Kuang Pharmaceutical Co., Ltd. functions as a pharmaceutical enterprise. Its comprehensive product range includes various sterile injectable forms such as parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed intravenous (IV) infusion bags. Additionally, it manufactures conventional dosage forms like tablets, capsules, oral suspensions, and topical applications. The company's offerings span a wide array of therapeutic categories, including treatments for cardiovascular, gastrointestinal, and nervous system disorders; alimentary and metabolic conditions; blood-related issues; antineoplastic and immunomodulatory agents; musculoskeletal and respiratory ailments; dermatological concerns; genito-urinary and sex hormone therapies; systemic hormones; and systemic antibacterials. Nang Kuang also supplies cosmetic products and comprehensive hospital solutions. Furthermore, Nang Kuang specializes in advanced pharmaceutical technologies, producing sterile and anticancer injectable products, controlled-release formulations (both injectable and oral), and oral disintegrating tablets. Founded in 1963, Nang Kuang Pharmaceutical Co., Ltd. is headquartered in Tainan City, Taiwan.
- ISIN
- TW0001752004
- Founded
- 1963
- Listed since
- Jan 20, 2022
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.